Dr. Tina Saw is the founder and CEO of Oral Genome, a healthcare startup that's developing saliva tests to detect and prevent oral diseases. In response to emailed questions, Saw talked about her company's approach.
The roster of speakers at INVEST Digital Health scheduled for September 18 in Dallas includes executives from health systems, healthcare entrepreneurs, and more. Register today!
Balancing healthcare benefits and insurance costs requires research. From becoming a Difference Card member to offering wellness resources, there are many ways to improve healthcare at low cost.
Meeting individuals where they are in their healthcare journey is essential for keeping lines of communication open and creating the right conditions for people to proactively seek out diabetes care.
In a fireside chat at INVEST Digital Health in Dallas, Polsinelli Healthcare M&A Co-chair Jonathan Henderson and Jim Walton, President of JWalton LLC discussed the healthcare preferences of different generations and how they will impact caregiving.
The INVEST Digital Health conference in Dallas, a collaboration between MedCity News and the Health Wildcatters accelerator, spotlights a wide range of hot topics in digital health, a startup pitch contest focused on femtech, and networking opportunities with investors and healthcare stakeholders. Register today!
Memorial Hermann Health System in Houston struck a new partnership with Midi Health, a virtual care clinic focused exclusively on women who are navigating menopause. The health system's two main goals for the partnership are to provide another point of access for its patients to manage their health at home and to gather data to inform decisions about which services it should offer to meet women’s healthcare needs.
Choosing the right software translates directly into better client management, operational efficiency and growth for your spa franchise. Discover which tool is best for your business.
The group of 10 startups in the accelerator have ambitions to improve early detection of lung cancer, eliminate contaminated needles, improve remote monitoring and provide new ways to treat head lice, among other goals.
Clinical trial design will be one of the topics discussed at the upcoming INVEST Digital Health conference in Dallas on October 26. THREAD Clinical Trial Design Director Noah Goodson highlighted some of the milestones the sector has seen in recent years.
Lexicon Pharmaceuticals drug Inpefa is now FDA-approved for heart failure. Inpefa is third in its class, but the biotech says its pill can reach a specific subset of patients, enabling it to stand apart from rival medicines from AstraZeneca and partners Eli Lilly and Boehringer Ingelheim.
The FDA has asked for more information about cardiac complications reported last year in a Phase 1 study for the Molecular Templates cancer drug, MT-0169. The partial clinical hold comes as the biotech works through a corporate restructuring as well as a second Nasdaq de-listing notice.
Leasing allows healthcare facilities more freedom to acquire up-to-date medical equipment without the need for immediate capital investment, opening doors for smaller and newer enterprises.
Skyclarys, a Reata Pharmaceuticals drug, is now approved for treating the rare neuromuscular disorder Friedreich’s ataxia. The decision makes the capsule the first therapy for a disease that’s rarer than either Duchenne muscular dystrophy or spinal muscular atrophy.
In an interview, the deputy director and chief innovation officer of Translational Research Institute for Space Health, headquartered at Baylor College of Medicine, described some of the group's work, adapting known tech for space applications and using space-based insights to improve healthcare at home.
Texas has the right environment to help ARPA-H achieve its promise of eliminating existing deficiencies in our national biomedical ecosystem, promoting the integration of multiple disciplines and institutions, and fully addressing persistent inequities in America’s health system.
An INVEST Digital Health panel discussion on investment beyond the traditional hubs of venture capital investment, touched on the role of Zoom in making it easier to maintain relationships with startups across the country in places like Indiana, Utah, Colorado and beyond.
Parth Desai, a principal with Flare Capital Partners, is one of three investor judges taking part in the Pitch Perfect competition at the INVEST Digital Health conference in Dallas September 28. He shares his perspective on the firm's investment strategy, collaborating with startups, and more. Register today!